Literature DB >> 18270812

Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.

Ana Osorio1, Alicia Barroso, Maria J García, Beatriz Martínez-Delgado, Miguel Urioste, Javier Benítez.   

Abstract

RAP80 and CCDC98 have arisen as new candidate breast cancer susceptibility genes, since they encode for two very recently identified BRCA1 interacting proteins. In this study we have performed the first mutational analysis of both genes in 168 multiple-case breast/ovarian cancer families, negative for mutations in BRCA1 or BRCA2. We have not found truncating mutations in any of the genes and only two missense variants, p.Tyr564His in RAP80, and p.Met299Ile in CCDC98 were found that could be suspected to have a pathogenic effect, although further analyses suggested that they were probably non deleterious. Our analysis suggests that RAP80 and CCDC98 do not play an important role as high penetrance breast cancer susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270812     DOI: 10.1007/s10549-008-9933-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Family-based association studies for next-generation sequencing.

Authors:  Yun Zhu; Momiao Xiong
Journal:  Am J Hum Genet       Date:  2012-06-08       Impact factor: 11.025

2.  A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.

Authors:  Jun Yan; Daniel Menendez; Xiao-Ping Yang; Michael A Resnick; Anton M Jetten
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

3.  RAP80 is critical in maintaining genomic stability and suppressing tumor development.

Authors:  Zhengyu Yin; Daniel Menendez; Michael A Resnick; John E French; Kyathanahalli S Janardhan; Anton M Jetten
Journal:  Cancer Res       Date:  2012-08-15       Impact factor: 12.701

Review 4.  Inherited mutations in breast cancer genes--risk and response.

Authors:  Andrew Y Shuen; William D Foulkes
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-05       Impact factor: 2.673

5.  Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions.

Authors:  Szilvia Solyom; Bernadette Aressy; Katri Pylkäs; Jeffrey Patterson-Fortin; Jaana M Hartikainen; Anne Kallioniemi; Saila Kauppila; Jenni Nikkilä; Veli-Matti Kosma; Arto Mannermaa; Roger A Greenberg; Robert Winqvist
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

6.  Molecular basis for impaired DNA damage response function associated with the RAP80 ΔE81 defect.

Authors:  Craig J Markin; Manoj K Rout; Leo Spyracopoulos
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

Review 7.  RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites.

Authors:  Jun Yan; Anton M Jetten
Journal:  Cancer Lett       Date:  2008-06-11       Impact factor: 8.679

8.  Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function.

Authors:  J Nikkilä; K A Coleman; D Morrissey; K Pylkäs; H Erkko; T E Messick; S-M Karppinen; A Amelina; R Winqvist; R A Greenberg
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

9.  Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer.

Authors:  Sylvie M Noordermeer; Marloes Wennemers; Saskia M Bergevoet; Adrian van der Heijden; Evelyn Tönnissen; Fred C G J Sweep; Joop H Jansen; Paul N Span; Bert A van der Reijden
Journal:  Breast Cancer Res Treat       Date:  2012-06-16       Impact factor: 4.872

10.  Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families.

Authors:  Mikko Vuorela; Katri Pylkäs; Robert Winqvist
Journal:  BMC Med Genet       Date:  2011-07-21       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.